Powered by: Motilal Oswal
30/01/2021 10:55:43 AM | Source: Emkay Global Financial Services Ltd
Buy Axis Bank Ltd For Target Rs. 850 - Emkay Global
News By Tags | #123 #413 #872 #2259 #1302
Buy Axis Bank Ltd For Target Rs. 850 - Emkay Global

Fortifying balance sheet for better tomorrow

* Axis reported a lower PAT of Rs11bn (vs. estimate of Rs19bn) mainly due to higher opex and elevated provisions. The bank has maintained a provisioning buffer of 2.1% of loans (best among peers) to largely absorb the asset quality pain in FY21 and walk into FY22 with a stronger balance sheet to ride the ensuing growth wave.

* Overall credit growth continues to disappoint (up 6% yoy) due to corporate drag, but clocks better growth in retail/SME. The bank resisted giving numerical guidance on growth in FY22, but we expect a better growth trajectory on the back of the strong balance sheet and reviving retail/corporate credit demand.

* Overall proforma GNPA ratio of 4.6% was in line with the expectation, while restructuring pool at 0.4% (with no major risk of spill over in Q4) was far lower than management’s own guidance, pointing to lower LLP in FY22/FY23 (160/110bps vs. 260bps in FY21).

* We like Axis’ aggressive stance to front-load provisions, which could depress RoA/RoE at 0.7%/7% in FY21E but should improve to 1.5%/15% by FY23E, aided by better growth, cost ratios and moderate provisions. Retain Buy with a TP of Rs850, valuing core bank at 1.9x FY23 ABV and subs at Rs40.

 

Growth remains elusive, but outlook better:

Overall credit growth was muted at 6% yoy/1% qoq due to a continued drag in corporate book as the bank consciously onboarding corporates at a lower rates. However, disbursements in secured retail segments like HL, LAP & Auto grew 23%/11%/10% yoy, while SBB disbursements grew 35% yoy, indicating accelerating growth momentum in retail. SME growth continued its positive stance with ECLGS disbursements amounting to Rs89bn. Reported NIM stood at 3.6% as the bank continued to reverse interest on proforma NPAs. Axis resisted giving numerical guidance on growth in FY22, but we expect a better growth trajectory for the bank on the back of the strong balance sheet and reviving retail/corporate credit demand.

 

Asset quality well in control, but prudently maintains higher provisioning buffer:

The bank’s reported GNPA level is low at 3.4% (down 74bps qoq) but proforma NPA stands at 4.6% (up 27bps qoq from 4.3% in Q2). Gross slippages as per IRAC norms were higher but in line at Rs67bn (4.9% of loans), mainly from retail including unsecured loans. However, overall restructuring pool turned out to be far lower at 0.4% of loans compared to an earlier estimate of 1.7%. That said, the bank continues to build a healthy provisioning buffer to meet any eventuality, with the specific PCR now at 79% and the overall contingent provisioning buffer at Rs118bn (2.1% of loans), including Rs50bn specifically for Covid-19.

 

Outlook and valuations:

We like Axis’ aggressive stance to front-load provisions, which could depress RoA/RoE at 0.7%/7% in FY21E but should improve to 1.5%/15% by FY23E, aided by better growth, cost ratios and moderate provisions. Retain Buy with a TP of Rs850, valuing core bank at 1.9x FY23 ABV and subs at Rs40. Key risks to our call include higher-thanexpected NPAs and management instability, which has moderated a bit recently.

 

To Read Complete Report & Disclaimer Click Here

 

For More  Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH000000354


Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here